doctor head
 
  pharmacy and drugs  
search Search
 
       About us       News      A-Z Drugs      Stores      Top Drugs      Contact  
  doctor doctor hand
 
  doctor legs  
 
 
 
 

  Diseases

  Newsletter
Subscribe to our newsletter:
Name:
E-mail:
    Search results
Search results for: ldl

1 - 5 of 7 <<previous | next>>

Drugs results:

Atorvastatin

Atorvastatin

Atorvastatin belong to a class of drug known as HMG CoA reductase inhibitor. This drug works by blocking the production of cholesterol (a type of fat) in the body. Indications: to reduce the amounts of low density lipoprotein or LDL (bad) cholesterol, more...

Rosuvastatin pills

Rosuvastatin

Rosuvastatin is an HMG CoA reductase inhibitor which is also known as “statins” group. A class of drug that works by blocking the production of cholesterol (a type of fat) in the body. Indications: for primary hypercholesterolemia (excessive choleteste more...

Simvastatin pills

Simvastatin

Simvastatin belong to a class of drug known as HMG CoA reductase inhibitor. This is an anti-hypercholesterolemic drug that works by blocking the production of cholesterol (a type of fat) in the body. Simvastatin is used to reduce the total amounts of chol more...

Baycol

Baycol

Baycol, often called Cerivastatin, blocks the production of cholesterol in your body. It reduces the amounts of LDL (bad cholesterol) and total cholesterol in your blood. It also reduces the triglycerides and apolipoprotein B (a protein your body needs t more...

Evista tablet

Evista

Evista, also known as Raloxifene, is an Estrogen Receptor Modulator, and Osteoporosis Prophylactic, and is used to help prevent and treat thinning of the bones. Evista is used only in postmenopausal women, and works like an estrogen to stop bone loss that more...

Diseases results:

Reduce cholesterol
High blood pressure
Osteoporosis
Heart attack
Insulin resistance
Endometriosis
Human papilloma viruses

Articles results:

Pharmacy Care Program Can Increase Medication Adherence In Elderly
Elderly patients will adhere more closely to their medication regimens if they have the benefit of a comprehensive pharmacy care program that includes patient education, specially packaged medications, and pharmacy follow-up, according to a study published today on the Journal of the American Medical Association's Web site (visit http://jama.ama-assn.org/).


Pfizer Ends Development Of Cholesterol Drug Torcetrapib After Deaths
Pfizer on Saturday announced it has ended clinical trials and development of its experimental cholesterol drug torcetrapib after an independent monitoring board said participants in a large trial who took the medication had an increased risk of death, the


Generic Medications Often More Expensive Than Expected
The Wall Street Journal on Tuesday examined how the prices of generic medications "can vary wildly and may not be nearly as cheap as expected." Patients with prescription drug coverage in most cases pay the lowest copayments for generic medications when they reach the market, but those without coverage are subject to different, and in some cases high, prices charged by pharmacies.


Up And Down With Cholesterol Management
The Business Intelligence firmLa Merie S.L. reported today that the US$ 20.392 bln branded statin market in 2006 has reached a plateau before the imminent implosion in 2010 by patent expiry of atorvastatin which posted 2006 sales of US$ 12.9 bln. Combinations of a potent statin with a cholesterol absorption inhibitor such as ezetimibe may capture a significant portion of this market, but therapies targeting at LDL cholesterol reduction have matured.




1 - 5 of 7 <<previous | next>>

© 2006-2010 pharmacy-and-drugs.com. All rights reserved.